Test text editor

NIGMS has approved our External Advisory Committee’s recommendation to fund the continued development of their biomedical innovations which represent various areas of technology, from medical devices, to diagnostics, to therapeutics.

“Our EAC members were delighted to see the high quality of the proposals we were asked to review, and wished there were more funds to fund them, as we had to pick the very best from those that made to the final group”, said Dr. McLoughlin, VP, Adaptive Biotechnologies, Chair of the EAC.